Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion and HIV

M P Busch1

  • 1Irwin Memorial Blood Centers, San Francisco, California, USA.

Current Opinion in Hematology
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Over ten years after the first AIDS cases, studies clarify the transfusion-associated epidemic's scope. Donor screening effectively safeguards the blood supply, minimizing HIV transmission risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimated US Trends in SARS-CoV-2 Spike Antibody Concentrations and Correlation to Risk of First-Time Infections Based on Blood Donations, 2022.

The Journal of infectious diseases·2025
Same author

Estimated dates of detectable infection (EDDIs) as an improvement upon Fiebig staging for HIV infection dating.

Epidemiology and infection·2020
Same author

Detection of Zika virus RNA in semen of asymptomatic blood donors.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Moving towards a reliable HIV incidence test - current status, resources available, future directions and challenges ahead.

Epidemiology and infection·2016
Same author

Manufacturing method affects mitochondrial DNA release and extracellular vesicle composition in stored red blood cells.

Vox sanguinis·2016
Same author

Incidence of West Nile virus infection in the Dallas-Fort Worth metropolitan area during the 2012 epidemic.

Epidemiology and infection·2016
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Area of Science:

  • Public Health
  • Virology
  • Hematology

Background:

  • The initial decade of the Acquired Immunodeficiency Syndrome (AIDS) epidemic saw significant transmission via blood transfusions, particularly affecting hemophiliacs.
  • Early efforts focused on identifying Human Immunodeficiency Virus (HIV) and implementing screening to protect the blood supply.

Purpose of the Study:

  • To review the extent of transfusion-associated AIDS in the early epidemic.
  • To evaluate the efficacy of donor screening measures in preventing HIV transmission through blood products.
  • To discuss ongoing efforts in developing advanced screening tests and viral inactivation methods.

Main Methods:

  • Analysis of epidemiological data from the early years of the AIDS epidemic.
  • Review of studies assessing the impact of donor screening protocols on HIV transmission rates.

Related Experiment Videos

  • Examination of research on novel diagnostic tests and viral inactivation technologies for blood safety.

    • Main Results:

    • Recent studies confirm a very low residual risk of HIV infection from screened blood and blood components.
    • Progressive donor screening measures have significantly enhanced the safety of the blood supply.
    • Research continues to advance screening sensitivity and viral clearance techniques.

    Conclusions:

    • The effectiveness of donor screening in preventing transfusion-associated HIV has been well-established.
    • Future challenges include evaluating and implementing new technologies to further minimize residual risks.
    • Continued vigilance and innovation are crucial for maintaining blood supply safety against viral threats.